Table 1.
Comparison of differentially expressed and regulated genes, molecules, signatures, and cell in primary tumor versus brain metastases.
| Increased abundance or expression in primary tumor |
Increased abundance or expression in BM |
Decreased abundance or expression in BM |
|---|---|---|
| CD4+ T cells | Mutations in STK11, FAM129C, ADAMTS, and APOBEC signature | Th1 and CD8 T genes |
| CD8+ T cells | TMB | Expression of VCAM1 |
| CD+ FOXP3 | Higher number of somatic mutations | Leukocyte extravasation signaling |
| PD-L1 expression* | Higher variant allelic frequency of mutated genes. | Th1 immune response |
| Invasion, metastasis, and metabolic-associated pathways | Reduced T cell heterogeneity | |
| Alterations in Hippo pathway | Dendritic cell maturation | |
| PD-L1 expression* | CD8+ T cells | |
| Macrophages (not TAMs) | ||
| CTLA-4 |
*Discordant results.